Birch Grove Capital LP

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Birch Grove Capital LP reported 0 stock positions worth $0. Its holdings were unchanged from Q4 2023.

Most Recent 13F
Q3 2024
Location
New York, NY
CIK
0001652355
Portfolio Value
$0 (Q1 2024)
SEC Filing
0000950142-24-001359 ↗ filed May 15, 2024

Holdings Value

0$1 Q1 2024: $0 $0 Q1 2024 Q2 2024: $0 Q2 2024 Q3 2024: $0 Q3 2024

Holdings 0 stocks · $0

None this quarter.

Options reported separately and not counted above: SPY puts ($9K).

Other holdings (5): bonds, preferreds, convertibles and warrants · $13.1M (not counted above)
SecurityClassShares / PrincipalValueChange
MITEK SYSTEMS INC (MITK 0.75 02/01/26) NOTE 0.750% 2/0 · principal 9,382,000$8.7MReduce -42.1%
KARYOPHARM THERAPEUTICS (KPTI 3 10/15/25) NOTE 3.000%10/1 · principal 6,000,000$3.2MReduce -25.0%
THE REALREAL INC (REAL 1 03/01/28) NOTE 1.000% 3/0 · principal 3,218,000$1.1MReduce -48.3%
CVIIW Churchill Capital Vii -CW28 *W EXP 02/29/202 80,000$24KNo change
MULTIPLAN CORPORATION *W EXP 02/13/202 75,000$8KNo change

Total filed on the 13F, all lines: $13.1M.

Portfolio Sells Q4 2023 → Q1 2024

None this quarter.

Portfolio Buys Q4 2023 → Q1 2024

None this quarter.

Options Activity Q4 2023 → Q1 2024

SPY SS SPDR S&P 500 ETF Trust-US put Add +42.6% 1,194,000 $9K

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

Notes & Other Activity Q4 2023 → Q1 2024

MITEK SYSTEMS INC (MITK 0.75 02/01/26) NOTE 0.750% 2/0 · principal Reduce -42.1% 9,382,000 $8.7M
KARYOPHARM THERAPEUTICS (KPTI 3 10/15/25) NOTE 3.000%10/1 · principal Reduce -25.0% 6,000,000 $3.2M
8X8 INC (EGHT 0.5 02/01/24) NOTE 0.500% 2/0 · principal Sold out 2,500,000 $2.5Mbefore exit
THE REALREAL INC (REAL 1 03/01/28) NOTE 1.000% 3/0 · principal Reduce -48.3% 3,218,000 $1.1M
CCV.WS Churchill Cap V Class A -CW27 *W EXP 10/29/202 Sold out 100,000 $600before exit
SKILW Skillsoft Corp. - CW *W EXP 06/11/202 Sold out 33,332 $103before exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2024 0$0
Q2 2024 0$0
Q1 2024 0$0